BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 26168152)

  • 21. How to treat patients with splanchnic vein thrombosis: recent advances.
    Valeriani E; Menichelli D; Palumbo IM; Cammisotto V; Pastori D; Pignatelli P
    Pol Arch Intern Med; 2023 May; 133(5):. PubMed ID: 37171365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical course and treatment of incidentally detected splanchnic vein thrombosis: an individual patient data meta-analysis.
    Candeloro M; Valeriani E; Monreal M; Ageno W; Riva N; Schulman S; Bang SM; Mellado M; Díaz-Peromingo JA; Moisés J; Díaz-Brasero AM; Garcia-Pagan JC; Perez-Campuzano V; Senzolo M; De Gottardi A; Di Nisio M
    J Thromb Haemost; 2023 Jun; 21(6):1592-1600. PubMed ID: 36907381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.
    Ageno W; Beyer Westendorf J; Contino L; Bucherini E; Sartori MT; Senzolo M; Grandone E; Santoro R; Carrier M; Delluc A; De Stefano V; Pomero F; Donadini MP; Tosetto A; Becattini C; Martinelli I; Nardo B; Bertoletti L; Di Nisio M; Lazo-Langner A; Schenone A; Riva N
    Blood Adv; 2022 Jun; 6(12):3569-3578. PubMed ID: 35439303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations.
    Cohen O; Caiano LM; Levy-Mendelovich S
    Thromb Res; 2024 Feb; 234():75-85. PubMed ID: 38183815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry.
    Verso M; Agnelli G; Ageno W; Imberti D; Moia M; Palareti G; Pistelli R; Cantone V;
    Thromb Res; 2012 Sep; 130(3):369-73. PubMed ID: 22583838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical history of cancer-associated splanchnic vein thrombosis.
    Valeriani E; Di Nisio M; Riva N; Caiano LM; Porreca E; Bang SM; Beyer-Westendorf J; Sartori MT; Barillari G; Santoro R; Kamphuisen PW; Alatri A; Malato A; Vidili G; Oh D; Schulman S; Ageno W;
    J Thromb Haemost; 2021 Apr; 19(4):983-991. PubMed ID: 33306241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study.
    Riva N; Ageno W; Poli D; Testa S; Rupoli S; Santoro R; Lerede T; Piana A; Carpenedo M; Nicolini A; Ferrini PM; Martini G; Mangione C; Contino L; Bonfanti C; Gresele P; Tosetto A
    Gastroenterol Res Pract; 2015; 2015():620217. PubMed ID: 26508913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Splanchnic Vein Thrombosis on Survival: 15-Year Institutional Experience With 1561 Cases.
    Wells PS; Theberge I; Bowdridge J; Kelly E; Kielar A; Forgie MA; John S; van Walraven C
    J Am Heart Assoc; 2020 Dec; 9(24):e016600. PubMed ID: 33269616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-associated splanchnic vein thrombosis: Clinical features upon diagnosis and short-term outcomes.
    García-Villa A; Criado-Álvarez JJ; Carnevali M; Aramberri M; Font C; Díaz-Pedroche C
    Thromb Res; 2023 Nov; 231():84-90. PubMed ID: 37832365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis.
    Candeloro M; Valeriani E; Monreal M; Ageno W; Riva N; Lopez-Reyes R; Peris ML; Beyer Westendorf J; Schulman S; Rosa V; López-Núñez JJ; Garcia-Pagan JC; Magaz M; Senzolo M; De Gottardi A; Di Nisio M
    Blood Adv; 2022 Aug; 6(15):4516-4523. PubMed ID: 35613465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry.
    Violi F; Corazza GR; Caldwell SH; Perticone F; Gatta A; Angelico M; Farcomeni A; Masotti M; Napoleone L; Vestri A; Raparelli V; Basili S;
    Intern Emerg Med; 2016 Dec; 11(8):1059-1066. PubMed ID: 27026379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombophilia, clinical factors, and recurrent venous thrombotic events.
    Christiansen SC; Cannegieter SC; Koster T; Vandenbroucke JP; Rosendaal FR
    JAMA; 2005 May; 293(19):2352-61. PubMed ID: 15900005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study.
    Dentali F; Ageno W; Witt D; Malato A; Clark N; Garcia D; McCool K; Siragusa S; Dyke S; Crowther M;
    Thromb Haemost; 2009 Sep; 102(3):501-4. PubMed ID: 19718470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis.
    McMurry H; Sabile JMG; Elstrott B; Chobrutskiy B; Mohinani A; Patel S; Gowda S; Martens K; Shatzel J
    Thromb Res; 2022 Aug; 216():1-7. PubMed ID: 35660708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Factors, Diagnosis, Management, and Outcome of Splanchnic Vein Thrombosis: A Retrospective Analysis.
    Derman BA; Kwaan HC
    Semin Thromb Hemost; 2015 Jul; 41(5):503-13. PubMed ID: 26080303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy.
    Condat B; Pessione F; Hillaire S; Denninger MH; Guillin MC; Poliquin M; Hadengue A; Erlinger S; Valla D
    Gastroenterology; 2001 Feb; 120(2):490-7. PubMed ID: 11159889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes.
    Kawata E; Siew DA; Payne JG; Louzada M; Kovacs MJ; Lazo-Langner A
    Thromb Res; 2021 Jun; 202():90-95. PubMed ID: 33798804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.